A
A

AstraZeneca


Balita

UK Stocks-Factors to watch on Sept 16

Sept 16 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower with futures down 0.62% on Friday * ASTRAZENECA/EMA: AstraZeneca AZN.L said its drug for preventing infant RSV, Beyfortus (nirsevimab), was recommended for approval in the European Union by a European Medicines Agency committee. * ASTRAZENECA: AstraZeneca's AZN.L antibody cocktail for preventing COVID-19, Evusheld, has now been recommended for treating the disease in the European Union (EU), the company said, potentially br
A
U

UK equities fall despite cooling August inflation

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * UK inflation falls for first time in nearly a year * Redrow says demand moderating in housing market * FTSE 100 down 1.5%, FTSE 250 off 1.7% (Updates with closing prices) By Johann M Cherian, Bansari Mayur Kamdar and Aniruddha Ghosh Sept 14 (Reuters) - Britain's main stock indexes fell on Wednesday after a surprise fall in consumer prices did little to calm speculation of a large intere
A
A
B
R
N
U

UK Stocks-Factors to watch on Sept 13

Sept 13 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower with futures FFIc1 down 0.11% on Tuesday. * FEVERTREE: Tonic maker Fevertree FEVR.L reported a fall in profit for the first half of the year, despite strong demand in Europe and the U.S. * OCADO: British online supermarket Ocado Retail OCDO.L downgraded its full-year outlook, as shoppers trade down to cheaper products and buy fewer items in a cost of living crisis.
A
T
U

UK Stocks-Factors to watch on Sept 13

Sept 13 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower with futures FFIc1 down 0.28% on Tuesday. * BARCLAYS: Barclays BARC.L is very "far along" in discussions with the U.S. Securities and Exchange Commission after it sold securities in breach of U.S. rules. * ASTRAZENECA: AstraZeneca AZN.L won the dismissal of a U.S. shareholder lawsuit claiming that it concealed problems in developing its COVID-19 vaccine.
A
T
U

UK Stocks-Factors to watch on Aug. 30

Aug 30 - Britain's FTSE 100 .FTSE index is seen opening lower, with futures down 0.21% on Tuesday. * BUNZL: British business supplies distributor Bunzl Plc BNZL.L raised its 2022 group operating margin outlook after it reported a more than 12% rise in half-year adjusted profit. * BP: BP Plc BP.L may begin restarting its 435,000 barrel-per-day (bpd) Whiting, Indiana, refinery this week after restoring electrical and cooling water systems knocked out by a Wednesday fire, sources familiar with plan
A
B
B
U

UK Stocks-Factors to watch on Aug 24

Aug 24 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening flat, with futures FFIc1 marginally down at 0.03% on Wednesday. * IWG: IWG Plc IWG.L said Charlie Steel has been appointed its next chief financial officer and will join the office rental firm's board before the end of this year. * ASTRAZENECA: AstraZeneca AZN.L may not stay in the vaccine business in the long run, its CEO told Reuters on Tuesday, showing how quickly fortunes have changed for the drugmaker that produced one of the
A
U

UK Stocks-Factors to watch on Aug 24

Aug 24 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening flat with futures marginally down at 0.03% on Wednesday. * ASTRAZENECA: AstraZeneca AZN.L may not stay in the vaccine business in the long run, its CEO told Reuters on Tuesday, showing how quickly fortunes have changed for the drugmaker that produced one of the first COVID-19 shots but has since lost out to rivals.
A
U

Financial Times - Aug 17

Aug 17 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Liz Truss and Rishi Sunak rule out second Scottish independence vote Link - UK launches legal proceedings against EU over access to Horizon programme Link - AstraZeneca sues former executive over move to rival GSK Link - Philips chief exits in wake of fallout from medical device recall Link Overview - Foreign secretary Liz Truss, f
A
G
P

UK Stocks-Factors to watch on August 16

August 16 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening flat on Tuesday with futures .FFIc1 up 0.33%. * AUTHENTIC BRANDS/TED BAKER: Juicy Couture and Forever 21 owner Authentic Brands AUTH.N will buy Ted Baker TED.L in a deal worth roughly 211 million pounds ($254.26 million). * BHP: BHP Group Ltd BHP.AX reported bumper profits on the back of gains in prices of coal and other commodities, and declined to rule out a second approach in its spurned $6 billion bid for OZ Minerals OZL.AX
A
U

UK first to approve Omicron COVID shot with Moderna nod

* UK's JCVI backs using bivalent shot in autumn booster campaign * Moderna sees Australia, Canada, EU approvals soon By Natalie Grover LONDON, Aug 15 (Reuters) - Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.
A
G
P
S

UK Stocks-Factors to watch on July 29

July 29(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 0.35%. * ASTRAZENECA: AstraZeneca AZN.L topped analyst expectations for second-quarter profit and revenue, helped by higher demand for its cancer medicines. * IAG: IAG IAG.L returned to quarterly profitability for the first time since the outbreak of the COVID-19 pandemic, following a "significant" increase in capacity.
A
C
E
G
G
I
I
J
R
S
U

UK Stocks-Factors to watch on July 29

July 29(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 0.2%. * STANCHART: Standard Chartered STAN.L on Friday reported that first-half pre-tax profit rose 19%, above market expectations, as the emerging markets-focused lender benefited from rising interest rates. * BUSINESS SENTIMENT: British business confidence fell this month to its lowest since March 2021 as companies worried about inflation, while pay pressures also increased, according to a
A
C
E
G
G
I
I
J
R
S
U

Switzerland signs contract for over 1,200 doses of AstraZeneca COVID treatment

BERLIN, July 20 (Reuters) - Switzerland has agreed to buy just over 1,200 doses of AstraZeneca's tixagevimab/cilgavimab, a combination drug designed to both prevent and treat COVID-19, the government said in a statement on Wednesday. The drug, originally only for preventive use, has also been found to be effective in treating people who already have COVID-19, the statement said citing recent studies.
A

UK Stocks-Factors to watch on July 19

July 19 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening lower on Tuesday, with futures FFIc1 down 0.4%. * ASTRAZENECA: AstraZeneca AZN.L said its cancer drug Enhertu was approved in the European Union for treating an aggressive form of breast cancer characterised by a high rate of the protein HER2, widening the therapy's indications for use in the region.
A
I
U

UK Stocks-Factors to watch on July 13

July 13 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening lower on Wednesday, with futures FFIc1 down 0.4%. * PAGEGROUP: Recruiter PageGroup Plc PAGE.L reported a 25.5% rise in quarterly profit, supported by strong hiring demand from companies amid staff shortages and higher resignations. * TULLOW: Tullow Oil TLW.L said it expected to make $200 million in free cashflow this year at an average oil price of $95 a barrel, adding that it sees no cashflow in the first half after an arbitrati
A
H
I
P
T
U

UK Stocks-Factors to watch on July 5

July 5 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Tuesday, with futures FFIc1 up 0.3%. * SAINSBURY'S: British supermarket group Sainsbury's SBRY.L reported a 4% fall in underlying sales in its first quarter, driven by weakness in general merchandise as cash-strapped consumers held back on discretionary spending. * CAIRN HOMES: Cairn Homes Plc CRN.I forecast total build cost inflation for 2022 to be higher at about 6%-7%, pressured by rising materials and labour prices,
A
U

UK Stocks-Factors to watch on July 1

July 1 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening lower on Friday, with futures FFIc1 down 0.58%. * ASTRAZENECA-OXFORD BIOMEDICA: Britain's Oxford Biomedica OXB.L said it had signed a new three-year agreement to manufacture AstraZeneca's AZN.L COVID-19 vaccine beyond 2022. * SHELL: Shell SHEL.L said it had suspended plans to sell its onshore oil assets in Nigeria, complying with a Supreme Court ruling that said it had to wait for the outcome of an appeal over a 2019 oil spill.
A
U

UK Stocks-Factors to watch on June 30

June 30 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening lower on Thursday, with futures FFIc1 down 1.64%. * IAG: International Airlines Group ICAG.L said it had converted options for 14 A320neo family Airbus jets, announced in 2013, into firm orders for 11 A320neos and three A321neos. * ASTRAZENECA: AstraZeneca AZN.L said its cancer drug Imfinzi, when given along with neoadjuvant chemotherapy in a late-stage trial, showed promise in helping patients with an aggressive form of lung can
A
A
B
C
O
T
K
U

FTSE 100 retreats from two-week high on slowdown worries

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Lookers rise on upbeat profit outlook * Anglo American, Diageo fall on Deutsche Bank downgrades * Cyclicals lead losses * FTSE 100 down 0.2%, FTSE 250 off 1.6% (Updates to close) By Amal S and Boleslaw Lasocki June 29 (Reuters) - Britain's top share index inched lower on Wednesday, as gains in healthcare shares were seen providing little support against growing concerns about a global recessi
A
A
D
O
A
N
U
U

UK Stocks-Factors to watch on June 27

June 27 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Monday, with futures FFIc1 up 0.47%. * ASTRAZENECA: AstraZeneca AZN.L said its cancer drugs Lynparza, developed with Merck & Co MRK.N and Enhertu, developed with Japan's Daiichi Sankyo 4568.T , were recommended for the treatment of some high-risk breast cancers in the European Union.
A
B
R
U



Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Gumagamit kami ng cookies para mabigyan ka ng mahusay na karanasan sa aming website. Magbasa pa o palitan ang iyong cookie settings.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.